Rongzhen Z. Luo

651 Dongfeng East Road
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Comparative Prognostic Utility of CPS+EG, Neo-Bioscore, and Conventional Staging Systems in Breast Cancer Patients Without Pathological Complete Response to Neoadjuvant Chemotherapy.

Comparative Prognostic Utility of CPS+EG, Neo-Bioscore, and Conventional Staging Systems in Breast Cancer Patients Without Pathological Complete Response to Neoadjuvant Chemotherapy.

Journal: Clinical breast cancer

Published: April 10, 2026

Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.

Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.

Journal: The New England journal of medicine

Published: October 15, 2025

Exploratory multi-cohort, multi-reader study on the clinical utility of a deep learning model for transforming cryosectioned to formalin-fixed, paraffin-embedded (FFPE) images in breast lesion diagnosis.

Exploratory multi-cohort, multi-reader study on the clinical utility of a deep learning model for transforming cryosectioned to formalin-fixed, paraffin-embedded (FFPE) images in breast lesion diagnosis.

Journal: Breast cancer research : BCR

Published: February 27, 2025

Prognostic value of tumor-infiltrating lymphocytes (TILs) in Luminal breast cancer: A novel computational method for assessing TILs abundance and spatial distribution patterns.

Prognostic value of tumor-infiltrating lymphocytes (TILs) in Luminal breast cancer: A novel computational method for assessing TILs abundance and spatial distribution patterns.

Journal: Breast (Edinburgh, Scotland)

Published: February 19, 2025

Albumin-bound paclitaxel plus anlotinib in patients with recurrent, platinum-resistant primary epithelial ovarian cancer (A-Plus): a phase II, single-arm, prospective study.

Albumin-bound paclitaxel plus anlotinib in patients with recurrent, platinum-resistant primary epithelial ovarian cancer (A-Plus): a phase II, single-arm, prospective study.

Journal: Frontiers of medicine

Published: November 17, 2024

Systematic Analysis of Factors Affecting Human Epidermal Growth Factor Receptor 2 Interpretation Consistency: Staining Protocols, Artificial Intelligence-Based Image Standardization, and Classification Criteria.

Systematic Analysis of Factors Affecting Human Epidermal Growth Factor Receptor 2 Interpretation Consistency: Staining Protocols, Artificial Intelligence-Based Image Standardization, and Classification Criteria.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: November 01, 2024

MRI findings of newly present benign focal hepatic observations following chemotherapy: distinct features in early- and late-term follow-up.

MRI findings of newly present benign focal hepatic observations following chemotherapy: distinct features in early- and late-term follow-up.

Journal: European radiology

Published: January 15, 2024

A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma.

A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma.

Journal: Nature communications

Published: December 30, 2023

Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.

Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.

Journal: Pathology

Published: September 19, 2023

Targeting the Cdc2-like kinase 2 for overcoming platinum resistance in ovarian cancer.

Targeting the Cdc2-like kinase 2 for overcoming platinum resistance in ovarian cancer.

Journal: MedComm

Published: September 05, 2023

Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer.

Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: July 05, 2023

The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages.

The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages.

Journal: Cancer cell international

Published: April 19, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026